Biocon is engaged in the business of manufacture of biotechnology products and research services.
Financial Results:
Biocon Ltd reported Revenues for Q1FY25 of ₹3,433.00 Crores up from ₹3,423.00 Crore year on year, a rise of 0.29%.
Total Expenses for Q1FY25 of ₹3,453.00 Crores up from ₹3,332.00 Crores year on year, a rise of 3.63%.
Consolidated Net Profit of ₹862.00 Crores up 478.52% from ₹149.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.49, up 553.57% from ₹0.84 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.